发明名称 2-AKYLAMINO-1-PHENYLETHANOL DERIVATIVE
摘要 PURPOSE: To provide the subject new compound having excellentβ3 -adrenergic receptor-stimulating activity and useful as an agent for prophylaxis and treatment for obesity, diabetes, hypersensitive intestinal diseases, acute or clonic diarrhea, etc. CONSTITUTION: This is a 2-alkylamino-1-phenylethanol derivative expressed by formula I R1 is a halogen or trifluoromethyl; R2 is H or a lower alkyl; A is a group of formula II [X is O, S or NR6 (R6 is H or a lower alkyl); R3 is H or a lower alkyl] or formula [U (R4 is H, a halogen, a lower alkyl, etc.), etc.; when A is selected from heterocyclic rings such as formula III, R4 can be bound only on the benzene ring, etc.} or its pharmaceutically allowable acid adduct. For instance, the compound is 2-[2-(indole-5-oxy)- methylethylamino[-1-(3-chlorophenyl)ethanol, etc. The compound of formula I is obtained e.g. by reacting a compound of formula TV with a compound of formula V.
申请公布号 JPH08165276(A) 申请公布日期 1996.06.25
申请号 JP19940333538 申请日期 1994.12.14
申请人 DAINIPPON PHARMACEUT CO LTD 发明人 KATO SHIROU;HARADA HIROSHI;HIROKAWA YOSHIMI;YOSHIDA NAOYUKI;KAWASHIMA KAZU
分类号 C07D237/32;A61K31/34;A61K31/341;A61K31/343;A61K31/38;A61K31/381;A61K31/40;A61K31/403;A61K31/404;A61K31/415;A61K31/4184;A61K31/42;A61K31/423;A61K31/425;A61K31/428;A61K31/44;A61K31/4402;A61K31/4406;A61K31/4409;A61K31/4418;A61K31/47;A61K31/496;A61K31/50;A61K31/502;A61K31/505;A61K31/517;A61P1/00;A61P3/04;A61P3/08;A61P3/10;A61P43/00;C07D207/335;C07D209/08;C07D209/14;C07D209/42;C07D213/36;C07D215/06;C07D231/56;C07D235/14;C07D239/90;C07D261/20;C07D263/56;C07D277/64;C07D307/52;C07D307/81;C07D333/20;(IPC1-7):C07D207/335 主分类号 C07D237/32
代理机构 代理人
主权项
地址